Evidence map›Paper›PMID 42619113›Full record

ArticleJournal of the American Chemical Society2026

Enantiodivergent Carbon-Phosphorus Bond Formation via Enzymatic Carbene Insertion.

Hayden M Carder, Ethan N Lin, Daniel Roth, Frances H Arnold

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hayden M CarderDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California91125, United States.ORCID 0000-0003-3811-5375
Ethan N LinDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California91125, United States.
Daniel RothDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California91125, United States.
Frances H ArnoldDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California91125, United States.

Funding

Arnold and Mabel Beckman Foundation NACaltech Summer Undergraduate Research Fellowship NA
6 · The paper itself

Abstract

Phosphorus is one of the six elements of life, yet enzymatic carbon-phosphorus (C-P) bond formation is exceedingly rare in nature. This gap in the biosynthetic toolkit is particularly consequential, given the prominence of stereogenic-at-phosphorus P(V) scaffolds in pharmaceuticals and agrochemicals, where the absolute configuration at phosphorus often directly governs biological activity. Despite significant advances in the asymmetric synthesis of P-stereogenic compounds, a general enzymatic platform based on direct C-P bond formation has not been realized. Here, we describe the discovery and directed evolution of Aeropyrum pernix protoglobin (ApePgb) variants that catalyze carbene insertion into the P-H bonds of secondary phosphine oxides and H-phosphinates. Mechanistic investigations reveal that carbene P-H insertion proceeds through a stereoretentive kinetic resolution. Directed evolution of a single protein scaffold produced an enantiodivergent enzyme platform that selectively delivers either P-configuration with high enantioselectivity across a broad substrate scope. The evolution campaign further revealed latent activity for nitrene P-H insertion, opening a path toward P-stereogenic phosphinamides and phosphonamidates through future evolution.

Indexed as

CarbonMethanePhosphorusStereoisomerismcarbeneCarbonMethanePhosphorus

Identifiers

PMID42619113
PMCPMC13495749

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.